Literature DB >> 18636672

Successful photodynamic therapy for biliary papillomatosis: a case report.

Lars-P Bechmann1, Philip Hilgard, Andrea Frilling, Brigitte Schumacher, Hideo-A Baba, Guido Gerken, Thomas Zoepf.   

Abstract

Papillomatosis of the bile duct is a rare disease with a high risk of malignant transformation. Therapeutical options include partial hepatectomy and liver transplantation. A previously healthy 65-years old male developed jaundice and right upper abdominal quadrant pain in 1996. A villous adenoma of the distal bile duct was diagnosed. A Whipple procedure was performed. In 2002 the patient turned symptomatic again. Another adenoma was found in the right hepatic duct resulting in a right hepatectomy. Two years later the patient again developed cholestasis. After drainage of the left hepatic duct with a percutaneous transhepatic cholangial drainage (PTCD) catheter, a recurrent biliary adenomatosis was diagnosed by cholangioscopy. As there was no surgical option left, the patient received photodynamic therapy (PDT) for the recurrent biliary papillomatosis. Three mo after he received further photodynamic therapies, the bile duct epithelium appeared normal and the patient had no signs of adenomatosis, both macroscopically and histologically. The follow-up cholangioscopy in late 2005 revealed only a small papilloma without the need for intervention. In early 2006, the patient died of multi organ failure without signs of extrahepatic cholestasis or cholangitis at the age of 75, 10 years after the diagnosis of biliary papillomatosis was established. The patient exceeded the average life expectancy of patients with biliary papillomatosis by far. Thus, PDT might be a sufficient therapeutic option for recurrent papillomatosis patients with no significant side effects.

Entities:  

Mesh:

Year:  2008        PMID: 18636672      PMCID: PMC2725388          DOI: 10.3748/wjg.14.4234

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Successful liver transplantation for diffuse biliary papillomatosis.

Authors:  J Dumortier; J Y Scoazec; P J Valette; T Ponchon; O Boillot
Journal:  J Hepatol       Date:  2001-10       Impact factor: 25.083

Review 2.  Endoscopic therapy for Barrett's esophagus.

Authors:  Ronald W Yeh; George Triadafilopoulos
Journal:  Gastrointest Endosc Clin N Am       Date:  2005-07

Review 3.  Well differentiated intrahepatic cholangiocarcinoma in the setting of biliary papillomatosis: a case report and review of the literature.

Authors:  Heather Cox; Michael Ma; Ronald Bridges; Estifanos Debru; Oliver Bathe; Francis Sutherland; Elijah Dixon
Journal:  Can J Gastroenterol       Date:  2005-12       Impact factor: 3.522

4.  Biliary papillomatosis.

Authors:  C M Lam; S T Yuen; W K Yuen; S T Fan
Journal:  Br J Surg       Date:  1996-12       Impact factor: 6.939

5.  Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.

Authors:  Thomas Zoepf; Ralf Jakobs; Joachim C Arnold; Darius Apel; Jürgen F Riemann
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

6.  Diagnostic and therapeutic aspects of endoscopic retrograde cholangiography in papillomatosis of the bile ducts: analysis of five cases.

Authors:  G D'Abrigeon; P Blanc; P Bauret; D Diaz; L Durand; J Michel; D Larrey
Journal:  Gastrointest Endosc       Date:  1997-09       Impact factor: 9.427

7.  Photodynamic therapy for palliation of nonresectable bile duct cancer--preliminary results with a new diode laser system.

Authors:  T Zoepf; R Jakobs; J C Arnold; D Apel; A Rosenbaum; J F Riemann
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

Review 8.  Endobronchial management of advanced lung cancer.

Authors:  M J Simoff
Journal:  Cancer Control       Date:  2001 Jul-Aug       Impact factor: 3.302

Review 9.  Precancerous lesions of intrahepatic cholangiocarcinoma.

Authors:  T Shimonishi; M Sasaki; Y Nakanuma
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

Review 10.  [Diffuse bile duct papillomatosis: high rate of recurrence and risk of malignant transformation].

Authors:  S Brönnimann; A Zimmermann; H U Baer
Journal:  Chirurg       Date:  1996-01       Impact factor: 0.955

View more
  4 in total

1.  Mucin-producing intrahepatic biliary papillomatosis.

Authors:  Sheng-Dong Wu; Cai-De Lu; Chang-Jiang Lu; Jing Huang; Jue Zhou
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

2.  Successful endoscopic procedures for intraductal papillary neoplasm of the bile duct: a case report.

Authors:  Kohei Tsuchida; Michiko Yamagata; Yasuyuki Saifuku; Dan Ichikawa; Kazunari Kanke; Toshimitsu Murohisa; Masaya Tamano; Makoto Iijima; Yukiko Nemoto; Wataru Shimoda; Toshiaki Komori; Hirokazu Fukui; Kazuhito Ichikawa; Hitoshi Sugaya; Kazuhito Miyachi; Takahiro Fujimori; Hideyuki Hiraishi
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

3.  Living donor liver transplantation for diffuse biliary papillomatosis with malignant change: A case report with 10-year follow-up.

Authors:  Jin Uk Choi; Shin Hwang; Dong-Hwan Jung; Gil-Chun Park; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Sung-Gyu Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-05-31

4.  Comparison of the Malignant Predictors in Intrahepatic and Extrahepatic Intraductal Papillary Neoplasm of the Bile Duct.

Authors:  Sung Yong Han; Dong Uk Kim; Hyeong Seok Nam; Dae Hwan Kang; Sung Ill Jang; Dong Ki Lee; Dong Woo Shin; Kwang Bum Cho; Min Jae Yang; Jae Chul Hwang; Jin Hong Kim; Hoonsub So; Sung Jo Bang; Min Je Sung; Chang-Il Kwon; Dong Wook Lee; Chang-Min Cho; Jae Hee Cho
Journal:  J Clin Med       Date:  2022-04-02       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.